(Q24250296)

27 June 2017

0 references

1 reference

title

Vaginal misoprostol for cervical ripening and induction of labour (English)

1 reference

27 June 2017

1 reference

1

G Justus Hofmeyr

0 references

A Metin Gülmezoglu

series ordinal

2

object named as

A M Gülmezoglu

1 reference

27 June 2017

2

A Metin Gülmezoglu

0 references

A Metin Gülmezoglu

series ordinal

2

object named as

A M Gulmezoglu

0 references

author name string

G J Hofmeyr

series ordinal

1

1 reference

27 June 2017

language of work or name

English

0 references

publication date

20 January 2003

0 references

1 January 2003

1 reference

Cochrane Database of Systematic Reviews

27 June 2017

2001

0 references

published in

1 reference

27 June 2017

CD000941

1 reference

27 June 2017

1

1 reference

Vaginally administered misoprostol for outpatient cervical ripening in pregnancies complicated by diabetes mellitus

27 June 2017

3

0 references

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000941

A comparison of differing dosing regimens of vaginally administered misoprostol for preinduction cervical ripening and labor induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000941

Disruption of prior uterine incision following misoprostol for labor induction in women with previous cesarean delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000941

Vaginal misoprostol for induction of labor: 25 vs. 50 microg dose regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000941

Comparison of 25 and 50 microg vaginally administered misoprostol for preinduction of cervical ripening and labor induction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000941

Labor induction post-term with 25 micrograms vs. 50 micrograms of intravaginal misoprostol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000941

A comparison of intermittent vaginal administration of misoprostol with continuous dinoprostone for cervical ripening and labor induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000941

Misoprostol: an effective agent for cervical ripening and labor induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000941

Six hourly vaginal misoprostol versus intracervical dinoprostone for cervical ripening and labor induction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000941

Prostaglandin E2 gel versus misoprostol for cervical ripening in patients with premature rupture of membranes after 34 weeks

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000941

Oral and vaginal misoprostol compared with dinoprostone for induction of labor: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000941

Randomized trial in multiparous patients: investigating a single vs. two-dose regimen of intravaginal misoprostol for induction of labor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000941

No benefit, but increased harm from high dose (100 microg) misoprostol for induction of labour: a randomised trial of high vs. low (50 microg) dose misoprostol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000941

Randomized study of vaginal misoprostol (PGE(1)) and dinoprostone gel (PGE(2)) for induction of labor at term

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000941

Comparative efficacy and cost of the prostaglandin analogs dinoprostone and misoprostol as labor preinduction agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000941

Induction of labour with a viable infant: a randomised clinical trial comparing intravaginal misoprostol and intravaginal dinoprostone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000941

Extemporaneous preparation of misoprostol gel for cervical ripening: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000941

Misoprostol versus low-dose oxytocin for cervical ripening: a prospective, randomized, double-masked trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000941

Randomized controlled trial of 50 and 100 mcg of misoprostol for induction of labor at term

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000941

Misoprostol is more efficacious for labor induction than prostaglandin E2, but is it associated with more risk?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000941

Uterine and fetal Doppler flow changes after misoprostol and oxytocin therapy for induction of labor in post-term pregnancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000941

Induction of labor in toxemia with misoprostol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000941

Misoprostol and dinoprostone therapy for labor induction: a Doppler comparison of uterine and fetal hemodynamic effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000941

A comparison of misoprostol and prostaglandin E2 gel for preinduction cervical ripening and labor induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000941

Misoprostol versus dinoprostone for cervical priming prior to induction of labour in term pregnancy: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000941

Vaginal misoprostol as an alternative to oxytocin for induction of labor in women with late fetal death

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000941

Intracervical misoprostol and prostaglandin E2 for labor induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000941

Labor induction with vaginal misoprostol and extra-amniotic prostaglandin F2alpha gel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000941

Induction of labor with intravaginal misoprostol versus intracervical dinoprostone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000941

The effect of tablet moistening on labor induction with intravaginal misoprostol: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000941

Oral or vaginal misoprostol for induction of labor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000941

Misoprostol versus oxytocin for labor induction in term and post-term pregnancy: randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000941

Dinoprostone versus misoprostol: a randomized study of nulliparous women undergoing induction of labor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000941

Labour characteristics and uterine activity: misoprostol compared with oxytocin in women at term with prelabour rupture of the membranes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000941

Uterine rupture during induction of labor at term with intravaginal misoprostol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000941

Misoprostol induction of labor among women with a history of cesarean delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000941

Misoprostol and illegal abortion in Rio de Janeiro, Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000941

Maternal mortality following the use of misoprostol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000941

A still birth and uterine rupture during induction of labour with oral misoprostol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000941

Uterine rupture associated with use of misoprostol for induction of labor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000941

Labor induction and meconium: in vitro effects of oxytocin, dinoprostone and misoprostol on rat ileum relative to myometrium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000941

Uterine contractility and induction of abortion in early pregnancy by misoprostol and mifepristone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000941

Misoprostol for cervical ripening and labor induction: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000941

In vitro characterization of prostanoid receptors on human myometrium at term pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000941

Labor induction with misoprostol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000941

Misoprostol as a labor induction agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000941

7 January 2021

Cervical ripening in the third trimester of pregnancy with intravaginal misoprostol: a double-blind, randomized, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000941

7 January 2021

Uterine hyperstimulation after low-dose prostaglandin E2 therapy: tocolytic treatment in 181 cases

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000941

7 January 2021

Labor induction with intravaginal misoprostol versus intracervical prostaglandin E2 gel (Prepidil gel): randomized comparison

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000941

7 January 2021

Cervical priming with oral misoprostol in pre-labor rupture of membranes at term

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000941

7 January 2021

Vaginal misoprostol for induction of labor: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000941

7 January 2021

Misoprostol and congenital malformations

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000941

7 January 2021

Misoprostol to induce labour

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000941

7 January 2021

A double-blind comparison of the safety and efficacy of intravaginal misoprostol and prostaglandin E2 to induce labor

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000941

7 January 2021

A randomized clinical trial comparing misoprostol with prostaglandin E2 gel for preinduction cervical ripening

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000941

7 January 2021

Randomized trial of two doses of the prostaglandin E1 analog misoprostol for labor induction

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000941

7 January 2021

Cervical ripening: a randomized comparison between intravaginal misoprostol and an intracervical balloon catheter combined with intravaginal dinoprostone

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000941

7 January 2021

Comparison of the safety and efficacy of intravaginal misoprostol (prostaglandin E1) with those of dinoprostone (prostaglandin E2) for cervical ripening and induction of labor in a community hospital

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000941

7 January 2021

Randomized comparison between intravaginal misoprostol and dinoprostone for cervical ripening and induction of labor

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000941

7 January 2021

Comparison of labor induction with misoprostol vs. oxytocin/prostaglandin E2 in term pregnancy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000941

7 January 2021

A comparative trial of labor induction with misoprostol versus oxytocin

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000941

7 January 2021

Outpatient cervical ripening with intravaginal misoprostol

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000941

7 January 2021

Oral administration of misoprostol for labor induction: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000941

7 January 2021

A randomized comparison between misoprostol and dinoprostone for cervical ripening and labor induction in patients with unfavorable cervices

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000941

7 January 2021

Absorption kinetics of misoprostol with oral or vaginal administration

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000941

7 January 2021

Labor induction with intravaginal misoprostol in term premature rupture of membranes: a randomized study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000941

7 January 2021

A randomized trial of misoprostol and oxytocin for induction of labor: safety and efficacy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000941

7 January 2021

Labor induction with prostaglandin E1 misoprostol compared with dinoprostone vaginal insert: a randomized trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000941

7 January 2021

Uterine rupture during induced trial of labor among women with previous cesarean delivery

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000941

7 January 2021

Preinduction cervical ripening with intravaginal prostaglandin E1 methyl analogue misoprostol: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000941

7 January 2021

A comparison of intravaginal misoprostol and intracervical prostaglandin E2 gel for ripening of unfavorable cervix and labor induction

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000941

7 January 2021

Intravaginal misoprostol as a cervical ripening agent

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000941

7 January 2021

Randomised trial of one versus two doses of prostaglandin E2 for induction of labour: 1. Clinical outcome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000941

7 January 2021

Misoprostol for induction of labour at term: a more effective agent than dinoprostone vaginal gel

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000941

7 January 2021

Labour characteristics and uterine activity: misoprostol compared with oxytocin in women at term with prelabour rupture of the membranes

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000941

7 January 2021

Uterine rupture associated with vaginal birth after cesarean section: a complication of intravaginal misoprostol?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000941

7 January 2021

10.1002/14651858.CD000941

Identifiers

DOI

2 references

Consolidated OpenCitations Corpus – April 2017

1766411

27 June 2017

1766411

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference

1766411

1 reference